Skip to main content
Article
The Economic Impact of Changing Levothyroxine Formulations in Difficult-to-Treat Hypothyroid Patients: An Evidence-Based Model
Pharmacoeconomics
  • R. Elmor
  • W. Sandulli
  • C. A. Carter
Document Type
Article
Date of Publication
1-1-2017
Citation Information
R. Elmor, W. Sandulli and C. A. Carter. "The Economic Impact of Changing Levothyroxine Formulations in Difficult-to-Treat Hypothyroid Patients: An Evidence-Based Model" Pharmacoeconomics Vol. 35 Iss. 2 (2017) p. 113
Available at: http://works.bepress.com/charles-carter/29/